V

VANOLI E.

Last name: VANOLI E.

2019 (v1)

Publication

Metadata-only

Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

Vanoli E. Montano N. De Angelis G.

Fingolimod exerts its therapeutic effect in multiple sclerosis by modulating sphingosine-1P receptors which are expressed in the heart mediating fingolimod first dose effects. Understanding potential interactions of baseline characteristics and autonomic profile with fingolimod first dose effects may add novel safety information and help...

Uploaded on: April 14, 2023